Cytosorbents Corp — Director's Dealing 2021

Nov 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2021-11-23

Reporting Person: BLOCH KATHLEEN P. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-23	Common Stock	P	4000	$4.98	Acquired	25000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	361433	Direct

Footnotes

F1: Includes (i) 10,000 shares held by the Reporting Person's husband in a 401(k) account and (ii) 15,000 shares held by the Reporting Person's husband in an IRA account (including the 4,000 shares reported on this Form 4). The Reporting Person may be deemed the beneficial owner of such shares.

F2: Includes the following RSUs that will be settled into common stock, par value $0.001 per share (the "Common Stock") upon a "Change In Control" of CytoSorbents Corporation (the "Company"), as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 8,800 RSUs granted on March 15, 2018, (b) 15,700 RSUs granted on February 24, 2017, (c) 47,000 RSUs granted on June 7, 2016 and (d) 110,000 RSUs granted on April 8, 2015.

F3: Includes the following RSUs (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the Reporting Person's continued service as of the applicable vesting date), and will be settled into common stock of the Company upon vesting: (a) 32,967 RSUs granted on April 12, 2021 and unvested as of the date hereof, and (b) 14,334 RSUs granted on February 28, 2020 and unvested as of the date hereof.

F4: Includes 132,632 shares of Common Stock owned by the Reporting Person.